Wren Advisers Daily Database

Wren Advisers Daily Update

Summary: Wednesday 5-August-2026

Australia	Value	Chg
S&P/ASX All Ordinaries Index	9,405.4	93.5
S&P/ASX 200 Index	9,227.8	82.0
ASX Volume (million)	---	---
ASX Advances	---	---
ASX Declines	---	---
ASX Value ($ million)	---	---
RBA cash rate (%)	4.35	0.00
90 day bank bill rate (%)	---	---
10 year Treasury bond yield (%)	4.90	-0.07
AUD/USD	0.7049	0.0030
AUD/TWI	65.4	0.1
USD/JPY	157.64	-0.07
EUR/USD	1.1537	0.0030

Asia	Value	Chg
Nikkei 225 Index	---	---
Hang Seng Index	---	---

Europe	Value	Chg
FTSE 100 Index	---	---
DAX Index	---	---

North America	Value	Chg
Dow Jones Industrial Average	---	---
NYSE Volume (million)	---	---
NYSE Advances	---	---
NYSE Declines	---	---
NASDAQ Composite Index	---	---
NASDAQ Volume (million)	---	---
NASDAQ Advances	---	---
NASDAQ Declines	---	---
US 3 month Treasury bill rate (%)	---	---
US 10 year Treasury bond yield (%)	---	---

Commodities	Value	Chg
London PM gold price (US$/oz)	---	---
WTI crude oil price (US$/bbl)	---	---

Market News

Local share market edges higher after further strong gains overnight on Wall Street. Resources are in demand, especially gold stocks like St Barbara (SBM) +10.3%, Capricorn Metals (CMM) +8.7% and Ora Banda Mining (OBM) +8.7%.

ABS cost of living indices show that many transfer recipients are experiencing higher inflation than the official consumer price index (CPI).

ABS Living Cost Indices (% change)

Endeavour Group (EDV) sheds 1.4% the group expected to recognise $311 million in after-tax asset impairments. Other financial year metrics are also disappointing with full-year sales up a modest 1.3% and underlying net profit down 14.8% to $363 million.

Light & Wonder (LNW) climbs 4.0% after posting a 26% lift in June quarter 2026 net profit to US$120 million. Revenue for the period was up 2.3% to US$828 million.

Pinnacle Investment Management (PMI) rallies 8.4% after posting a 31.5% increase in full-year net profit. Total income was up 70.1% to $109.7 million.

S&P/ASX Sector Indices (% change)

Argo Investments (ARG) adds 2.1% announcing it will now pay quarterly dividends to compete with exchange-traded funds (ETFs). The company also releases its full-year results showing a flat net profit and marginal revenue growth of 2.2%.

Neuren Pharmaceuticals (NEU) soars 16.3% after saying that net sales of its Rett Syndrome drug DAYBUE were US$125 million in the June quarter 2026.

Radiopharmaceuticals company Clarity Pharmaceuticals (CU6) jumps 7.1% after reporting promising trial results in the diagnosis of prostate cancer.

S&P/ASX Market Moving Stocks

WARNING: While all care has been taken in the preparation of this database (using sources believed to be reliable and accurate), we do not accept responsibility for any loss suffered by any person arising from reliance on this information. This update must not be reproduced in whole or in part without the express written consent of Wren Advisers. The information is of a general nature only and has not been prepared to take into account any particular investor's objectives, financial situation or needs. Investors should seek professional advice from a financial adviser before making any investment decisions based on this information. All figures in Australian dollars unless otherwise indicated.